Bladder Cancer: Health Services

(asked on 23rd June 2025) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the adequacy of care for bladder cancer in each region; and if he will hold discussions with NICE guidelines on the time taken to update its guidelines on bladder cancer care.


Answered by
Ashley Dalton Portrait
Ashley Dalton
Parliamentary Under-Secretary (Department of Health and Social Care)
This question was answered on 1st July 2025

The Department is committed to improving cancer care in all regions of England, including for bladder cancer patients. The National Health Service has exceeded their pledge to deliver an extra two million appointments, having now delivered over three million more appointments as the first step to ensuring earlier and faster access to diagnosis and treatment.

The National Cancer Plan, due for publication later this year, will include further details on how the NHS will improve care for bladder cancer patients, as well as speeding up diagnosis and access to treatment. Furthermore, it will ensure that patients have access to the latest treatments and technology. These actions will help bring this country’s cancer survival rates back up to the standards of the best in the world.

Reducing inequalities and variation in cancer diagnosis and treatment is a priority for the Government and will be included as a key area of focus in the plan.

The National Institute for Health and Care Excellence (NICE) is in the process of updating its guideline on the diagnosis and management of bladder cancer, following the NICE prioritisation board’s decision that this work should proceed. The NICE’s current guideline on the diagnosis and management of bladder cancer is available at the following link:

https://www.nice.org.uk/guidance/ng2

This work will be a partial update of the guideline, to include the recommendations on treating non-muscle invasive bladder cancer and muscle-invasive bladder cancer, and on managing locally advanced or metastatic muscle-invasive bladder cancer. NICE also plans to update the section of the guideline on diagnosing and staging.

NICE will set a provisional timeline for the update in due course and will share updates on its website as the update progresses.

Reticulating Splines